These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 11301393
1. Aspects of intracranial and spinal tumors in patients with Down syndrome and report of a rapidly progressing Grade 2 astrocytoma. Satgé D, Monteil P, Sasco AJ, Vital A, Ohgaki H, Geneix A, Malet P, Vekemans M, Réthoré MO. Cancer; 2001 Apr 15; 91(8):1458-66. PubMed ID: 11301393 [Abstract] [Full Text] [Related]
2. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Leins A, Riva P, Lindstedt R, Davidoff MS, Mehraein P, Weis S. Cancer; 2003 Dec 01; 98(11):2430-9. PubMed ID: 14635078 [Abstract] [Full Text] [Related]
3. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma. Perry A, Aldape KD, George DH, Burger PC. Cancer; 2004 Nov 15; 101(10):2318-26. PubMed ID: 15470710 [Abstract] [Full Text] [Related]
4. Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Godard S, Getz G, Delorenzi M, Farmer P, Kobayashi H, Desbaillets I, Nozaki M, Diserens AC, Hamou MF, Dietrich PY, Regli L, Janzer RC, Bucher P, Stupp R, de Tribolet N, Domany E, Hegi ME. Cancer Res; 2003 Oct 15; 63(20):6613-25. PubMed ID: 14583454 [Abstract] [Full Text] [Related]
5. An excess of testicular germ cell tumors in Down's syndrome: three case reports and a review of the literature. Satgé D, Sasco AJ, Curé H, Leduc B, Sommelet D, Vekemans MJ. Cancer; 1997 Sep 01; 80(5):929-35. PubMed ID: 9307193 [Abstract] [Full Text] [Related]
6. Spinal cord malignant astrocytomas. Clinicopathologic features in 36 cases. Santi M, Mena H, Wong K, Koeller K, Olsen C, Rushing EJ. Cancer; 2003 Aug 01; 98(3):554-61. PubMed ID: 12879473 [Abstract] [Full Text] [Related]
7. [Classification of the astrocytic gliomas. Brief comments]. Pérez-Ortiz L, Galarraga J, Gómez-Suárez H, Tamayo-Suárez JD. Rev Neurol; 2003 Aug 01; 31(12):1180-3. PubMed ID: 11205555 [Abstract] [Full Text] [Related]
8. [Molecular pathology of brain tumors]. Sanz Esponera J. An R Acad Nac Med (Madr); 2005 Aug 01; 122(1):191-6. PubMed ID: 16173698 [Abstract] [Full Text] [Related]
9. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis. Ljubimova JY, Lakhter AJ, Loksh A, Yong WH, Riedinger MS, Miner JH, Sorokin LM, Ljubimov AV, Black KL. Cancer Res; 2001 Jul 15; 61(14):5601-10. PubMed ID: 11454714 [Abstract] [Full Text] [Related]
10. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma. Somasundaram K, Reddy SP, Vinnakota K, Britto R, Subbarayan M, Nambiar S, Hebbar A, Samuel C, Shetty M, Sreepathi HK, Santosh V, Hegde AS, Hegde S, Kondaiah P, Rao MR. Oncogene; 2005 Oct 27; 24(47):7073-83. PubMed ID: 16103883 [Abstract] [Full Text] [Related]
11. Molecular pathogenesis of pediatric astrocytic tumors. Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N. Neuro Oncol; 2007 Apr 27; 9(2):113-23. PubMed ID: 17327574 [Abstract] [Full Text] [Related]
12. Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival. Kunwar S, Mohapatra G, Bollen A, Lamborn KR, Prados M, Feuerstein BG. Cancer Res; 2001 Oct 15; 61(20):7683-8. PubMed ID: 11606412 [Abstract] [Full Text] [Related]
13. Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort. Pollack IF, Finkelstein SD, Burnham J, Holmes EJ, Hamilton RL, Yates AJ, Finlay JL, Sposto R, Children's Cancer Group. Cancer Res; 2001 Oct 15; 61(20):7404-7. PubMed ID: 11606370 [Abstract] [Full Text] [Related]
14. Cytogenetic and molecular cytogenetic analyses in diffuse astrocytomas. Krupp W, Geiger K, Schober R, Siegert G, Froster UG. Cancer Genet Cytogenet; 2004 Aug 15; 153(1):32-8. PubMed ID: 15325091 [Abstract] [Full Text] [Related]
15. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine. Stege EM, Kros JM, de Bruin HG, Enting RH, van Heuvel I, Looijenga LH, van der Rijt CD, Smitt PA, van den Bent MJ. Cancer; 2005 Feb 15; 103(4):802-9. PubMed ID: 15637687 [Abstract] [Full Text] [Related]
16. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas. Maris C, Rorive S, Sandras F, D'Haene N, Sadeghi N, Bièche I, Vidaud M, Decaestecker C, Salmon I. Neuropathol Appl Neurobiol; 2008 Jun 15; 34(3):316-29. PubMed ID: 17983425 [Abstract] [Full Text] [Related]
17. Gene expression profiling in the adult Down syndrome brain. Lockstone HE, Harris LW, Swatton JE, Wayland MT, Holland AJ, Bahn S. Genomics; 2007 Dec 15; 90(6):647-60. PubMed ID: 17950572 [Abstract] [Full Text] [Related]
18. 10q25.3 (DMBT1) copy number changes in astrocytoma grades II and IV. Wessels PH, Twijnstra A, Kubat B, Ummelen MI, Claessen SM, Sciot R, Merlo A, Ramaekers FC, Speel EJ, Hopman AH. Genes Chromosomes Cancer; 2004 Jan 15; 39(1):22-8. PubMed ID: 14603438 [Abstract] [Full Text] [Related]
19. Sudden death due to primary intracranial neoplasms. A forensic autopsy study. Vougiouklakis T, Mitselou A, Agnantis NJ. Anticancer Res; 2006 Jan 15; 26(3B):2463-6. PubMed ID: 16821633 [Abstract] [Full Text] [Related]
20. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part I). Cheon MS, Kim SH, Yaspo ML, Blasi F, Aoki Y, Melen K, Lubec G. Amino Acids; 2003 Jan 15; 24(1-2):111-7. PubMed ID: 12624742 [Abstract] [Full Text] [Related] Page: [Next] [New Search]